Aurinia Pharmaceuticals
AUPH
#5015
Rank
C$1.95 B
Marketcap
$13.68
Share price
-0.83%
Change (1 day)
9.30%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -C$19.82 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are C$0.22 Billion. In 2023 the company made an earning of -C$0.11 Billion, an increase over its 2022 earnings that were of -C$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$19.82 Million-81.47%
2023 -C$0.11 Billion-31.8%
2022 -C$0.16 Billion-39.4%
2021 -C$0.26 Billion61.9%
2020 -C$0.16 Billion-9.73%
2019 -C$0.18 Billion92.65%
2018 -C$91.92 Million36.39%
2017 -C$67.4 Million106.29%
2016 -C$32.67 Million-15.4%
2015 -C$38.62 Million65.84%
2014 -C$23.29 Million129.82%
2013 -C$10.14 Million-26.6%
2012 -C$13.81 Million
2010 -C$7.82 Million-39.22%
2009 -C$12.86 Million-43.78%
2008 -C$22.88 Million-53.19%
2007 -C$48.87 Million42.97%
2006 -C$34.18 Million-23.03%
2005 -C$44.41 Million36.1%
2004 -C$32.63 Million172.57%
2003 -C$11.98 Million484.61%
2002 -C$2.05 Million
2000 -C$9.73 Million453.81%
1999 -C$1.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$7.11 B-32,918.65%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$7.86 Million-63.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$31.68 Million 46.09%๐Ÿ‡บ๐Ÿ‡ธ USA